Soberlink - MAP Outcomes Study Protocol

Soberlink Healthcare

Status

Terminated

Conditions

Alcohol Addiction

Treatments

Device: Soberlink Cellular Device

Study type

Observational

Funder types

Industry

Other

Identifiers

NCT03190356

SLMAPPROT-2017-001

Details and patient eligibility

About

The purpose of this study is to show the effectiveness of Soberlink's remote alcohol monitoring system integrated with MAP's patient engagement platform (EHR) to monitor a sample size of at-risk alcohol use disorder (AUD) population. Ultimately, this data is leveraged to improve clinical outcomes and manage financial risk through facilitating early interventions and other means of mitigating recidivism and costly treatment episodes from AUD population.

Full description

The study will include 30 Clients with a primary or secondary diagnosis of alcohol use disorder (AUD) and are enrolled in MAP's System where dedicated Case Managers are monitoring the Client's relapse risk levels. Soberlink's remote alcohol system will provide data to inform the Case Manager if the Client has relapsed or is at risk of relapsing through the use of testing data compiled by the Soberlink System. Integrating Soberlink results into MAP's EMR will allow Case Manager to make better clinical decisions and reduce costs by mitigating the chances recidivism through early intervention. Clients will use the Soberlink Device for a period of 90 days.

Enrollment

6 patients

Sex

All

Ages

21 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Male or female subject between ages of 21-65 years old
Subject is active in MAP's program with recovery support services
Subject has received acute professional treatment in the last 120 days
Primary or secondary diagnosis is Alcohol Use Disorder
Subject willing to use Soberlink Device to provide BAC
Subject is willing to discuss Soberlink test results with case manager
Subject is willing to sign a Soberlink Client Agreement
Subject is English speaking and reading

Exclusion criteria

Alcohol Use Disorder is not a primary or secondary diagnosis
Subject is currently taking anti-alcohol medications
Subject will not be in the United States through duration of study
Subject is unwilling to properly use the device
Subject is non-English speaking and reading
Subject is a child, adolescent, cognitively impaired, diagnosed with a mental disorder, such as schizophrenia